IPRASENSE
PrivateLast Round
Grant
Nov 1, 2021
Total Funding Raised
$1.89M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
IPRASENSE is a life sciences company that develops and commercializes innovative cell culture monitoring equipment, including automated cell counters and viability analyzers.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Medical Devices, Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
IPRASENSE Comparables
Compare IPRASENSE with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Phase Holographic Imaging AB | 81% | |
| Aligned Genetics | 79% | |
| Nanolive SA | 77% |
IPRASENSE Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 1, 2021 | ||||
| Accelerator | Jul 1, 2019 | ||||
| Grant | May 1, 2018 |
IPRASENSE Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovative Health Initiative | Grant |
| European Commission | Grant |
| SATT AxLR | Accelerator |
| Bpifrance | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased from 0 to 2, representing 67% of headcount.
- Jul 2, 2025
Monthly visitors increased 49% MoM.
IPRASENSE Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about IPRASENSE's valuation, stock price, and market status.
Is IPRASENSE a public or private company?
IPRASENSE is a private company.
What is the current stock price of IPRASENSE?
IPRASENSE is a private company with no public stock price. No recent secondary market data is available.
How much is IPRASENSE worth (valuation)?
Valuation information for IPRASENSE is not publicly available.
Can I buy IPRASENSE stock?
IPRASENSE shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was IPRASENSE's last funding round?
IPRASENSE's most recent funding round was Grant on November 1, 2021.
Who are the main investors in IPRASENSE?
Key investors in IPRASENSE include Innovative Medicines Initiative 2 Joint Undertaking, SATT AxLR, Bpifrance.
Will IPRASENSE IPO soon?
No public IPO plans have been announced for IPRASENSE.
How can I track IPRASENSE secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor IPRASENSE's secondary market activity and sign up for updates.